21 CFR 862.2270 - Thin-layer chromatography system for clinical use.

Code of Federal Regulations - Title 21: Food and Drugs

Linked as:

Text


Title 21: Food and Drugs

CHAPTER I: FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED)

SUBCHAPTER H: MEDICAL DEVICES

PART 862: CLINICAL CHEMISTRY AND CLINICAL TOXICOLOGY DEVICES

Subpart C: Clinical Laboratory Instruments

862.2270 - Thin-layer chromatography system for clinical use.

(a) Identification. A thin-layer chromatography (TLC) system for clinical use is a device intended to separate one or more drugs or compounds from a mixture. The mixture of compounds is absorbed onto a stationary phase or thin layer of inert material (e.g., cellulose, alumina, etc.) and eluted off by a moving solvent (moving phase) until equilibrium occurs between the two phases.

(b) Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to ? 862.9. Particular components of TLC systems, i.e., the thin-layer chromatography apparatus, TLC atomizer, TLC developing tanks, and TLC ultraviolet light, are exempt from the current good manufacturing practice requirements of the quality system regulation in part 820 of this chapter, with the exception of ? 820.180 of this chapter, with respect to general requirements concerning records, and ? 820.198 of this chapter, with respect to complaint files.

[52 FR 16122, May 1, 1987, as amended at 65 FR 2309, Jan. 14, 2000]

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company